US regulatory approaches to chemistry, manufacturing, and controls for botanical drug products

被引：0
|
作者：
Rajiv Agarwal
机构：
[1] US Food and Drug Administration,Office of New Drug Quality Assessment, Office of Pharmaceutical Science
来源：
Journal of Translational Medicine | / 10卷 / Suppl 2期
关键词：
Dietary Supplement; Plant Part; General Pathway; Drug Substance; Plant Origin;
D O I：
10.1186/1479-5876-10-S2-A40
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Chemistry and regulatory in drug development
    Charpentier, Bonnie A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [22] Predictive toxicology for regulatory decisions: Implementing new approaches at US Food and Drug Administration
    Fitzpatrick, Suzanne C.
    TOXICOLOGY IN VITRO, 2020, 63
  • [23] Quality issues of popular botanical products in the us market.
    Wang, MF
    Simon, JE
    Liang, CP
    Ho, CT
    Sang, SM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U47 - U47
  • [24] Lessons from Natural Products Chemistry Can Offer Novel Approaches for Synthetic Chemistry in Drug Discovery Miniperspective
    Vasilevich, Natalya I.
    Kombarov, Roman V.
    Genis, Dmitry V.
    Kirpichenok, Michael A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) : 7003 - 7009
  • [25] Development and Validation of Matrix of Chemistry, Manufacturing, and Control (MoCMC) System for Intramammary Drug Products (IMM)
    Helal, Nada A.
    Martinez, Marilyn N.
    Longstaff, David G.
    Rahman, Ziyaur
    Nutan, Mohammad T. H.
    Khan, Mansoor A.
    PHARMACEUTICAL RESEARCH, 2024, 41 (05) : 983 - 1006
  • [26] Reinventing FDA, part 5: Chemistry, manufacturing, and controls
    Morgan, J
    Chew, NJ
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (06): : 12 - +
  • [27] Considerations on chemistry, manufacturing, and control of stem cell products for Investigational New Drug application in China
    Lu, Jiaqi
    Wei, Wei
    BIOLOGICALS, 2020, 68 : 3 - 8
  • [28] A pharma stepwise approach to the evaluation of Nitrosamines in drug products: regulatory scenario and the role of in silico approaches
    Zucchi, S.
    Pavan, M.
    Mastrocola, E.
    Bassan, A.
    Durando, L.
    Ragni, L.
    TOXICOLOGY LETTERS, 2021, 350 : S217 - S217
  • [29] Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan
    Hiroko Shibata
    Hiroyuki Yoshida
    Ken-ichi Izutsu
    Chikako Yomota
    Yukihiro Goda
    Haruhiro Okuda
    AAPS Open, 2 (1)
  • [30] Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India
    Lee, Sau L.
    Saluja, Bhawana
    Garcia-Arieta, Alfredo
    Lima Santos, Gustavo Mendes
    Li, Ying
    Lu, Sarah
    Hou, Shuguang
    Rebello, Juliet
    Vaidya, Abhijit
    Gogtay, Jaideep
    Purandare, Shrinivas
    Lyapustina, Svetlana
    AAPS JOURNAL, 2015, 17 (05): : 1285 - 1304
12345